Ben Wu, RPh (Canada), MBA, was the former General Manager for Sanofi-Genzyme in China. He was the founding CEO of Citrine Medicine and head of rare diseases at Canbridge Pharmaceuticals (1228.HK). He has been instrumental in numerous international licensing deals and fund raising efforts. Ben has close to 30 years of experience in the pharmaceutical industry, holding senior management positions covering Asia Pacific for Sanofi and Johnson & Johnson.